Video: The Future of Ketamine Therapy

Breaking Through Investment Opportunities with Breakthrough Psychedelics

PsyTech has gathered the leading clinicians, psychiatrists, psychotherapists and anesthesiologists in the ketamine therapy industry. This group includes Casey E. Paleos, M.D., Science Director of Mindbloom; Julane Andries, LMFT Senior Psychotherapist at the Center for Transformational Psychotherapy; Steven L. Mandel, M.D., Founder and President of the Ketamine Clinics of Los Angeles; Abid Nazeer, M.D., Founder and President of ; Phil Wolfson, M.D., CEO of Non-Profit Ketamine Research Foundation; and Moderator Mark Braunstein, D.O., Founder and CEO of Reconscious Medical. In this lively debate, our panel discusses the merits of the different available therapeutic approaches to ketamine-assisted treatment -- from who it's right for to the myriad ways to administer this potentially groundbreaking therapy.

Meet the Experts

Julane Andries

Julane Andries, LMFT

Senior Psychotherapist Center for Transformational Psychotherapy

Phil Wolfson, MD

Phil Wolfson MD

CEO non-profit Ketamine Research Foundation

Steven L. Mandel MD

Founder & President Ketamine Clinics Los Angeles

Abid Nazeer

Abid Nazeer MD

Founder and President APS Ketamine

Casey A. Paleos MD

Science Director Mindbloom

Moderator: Mark Braunstein DO

Founder and CEO Reconscious Medical

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on pinterest